Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0GT5M
|
|||
Drug Name |
Tetra-azabenzo[e]azulene derivative 2
|
|||
Synonyms |
PMID25776143-Compound-6
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Hoffmann-La Roche, Inc
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Vasopressin V1a receptor (V1AR) | Target Info | Inhibitor | [1] |
Target's Patent Info | Vasopressin V1a receptor (V1AR) | Target's Patent Info | [1] | |
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Vascular smooth muscle contraction | ||||
Reactome | Vasopressin-like receptors | |||
G alpha (q) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Vasopressin V1a and V1b receptor modulators: a patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jun;25(6):711-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.